Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis by unknown
RESEARCH Open Access
Age-related increase in amyloid plaque burden is
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Abstract
Introduction: The current pathological confirmation of the diagnosis of Alzheimer’s disease (AD) is still based on
postmortem identification of parenchymal amyloid beta (Ab) plaques, intra-neuronal neurofibrillary tangles, and
neuronal loss. The memory deficits that are present in the early stages of AD are linked to the dysfunction of
structures in the entorhinal cortex and limbic system, especially the hippocampus and amygdala. Using the CRND8
transgenic mouse model of amyloidosis, which over-expresses a mutant human amyloid precursor protein (APP)
gene, we evaluated hippocampus-dependent contextual and amygdala-dependent tone fear conditioned (FC)
memory, and investigated the relationship between the fear memory indices and Ab plaque burden.
Methods: Mice were tested at three, six, and 12 months of age, which corresponds to early, mild, and severe Ab
plaque deposition, following a cross-sectional experimental design. We used a delay version of the fear
conditioning paradigm in which tone stimulus was co-terminated with foot-shocks during exploration of the
training chamber. The Ab plaque burden was evaluated at each age after the completion of the behavioral tests.
Results: CRDN8 mice showed context fear memory comparable to control mice at three and six months, but were
significantly impaired at 12 months of age. In contrast, the tone fear memory was significantly impaired in the
model at each age of testing. The Ab plaque burden significantly increased with age, and was correlated with the
overall impairment in context and tone fear memory in the CRND8 mice within the studied age.
Conclusions: Our data extend previous studies showing that other APP mouse models exhibit impairment in fear
conditioned memory, by demonstrating that this impairment is progressive and correlates well with an overall
increase in Ab burden. Also, the demonstrated greater sensitivity of the tone conditioning test in the identification
of age dependent differences between CRND8 and control mice suggests that this paradigm might be particularly
suitable in studies evaluating potential therapeutics related to memory improvement in mouse models of
amyloidosis.
Introduction
Alzheimer’s disease (AD) is the leading cause of dementia
in the elderly, affecting more than 35 million people world-
wide [1]. Currently, confirmation of a clinical diagnosis of
AD still requires post mortem identification of parenchy-
mal amyloid beta (Ab) deposits and intra-neuronal neurofi-
brillary tangles composed of abnormally phosphorylated
tau protein [2-5] and severe loss of brain tissue [6-8].
In the near future, cerebrospinal fluid (CSF) measures of
Ab and tau or amyloid imaging may be utilized to provide
pre-mortem confirmation of the AD diagnosis. Senile amy-
loid plaques are found in large numbers in the limbic sys-
tem, including amygdala (AD is often referred to as ‘limbic
dementia’ [9]), hippocampus, and associative cortices
which are affected first during the disease progression
[10-18].
Transgenic mice, over-expressing the mutated human
amyloid precursor protein (APP) gene, provide a valuable
tool for investigating the associations between amyloidosis,
neuronal dysfunction, and cognitive impairment [19-23].
In the present study, we investigated the age-progressing
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Ab plaque burden and corresponding changes in condi-
tioned fear memory in a transgenic mouse model, denoted
CRND8. Previous characterizations of this model revealed
impairments in spatial reference [24-26] and spatial work-
ing [27] memory, and in associative learning of condi-
tioned taste aversion [28]. Other abnormalities reported in
CRND8 mice included increased stereotypic behavior [29],
brain inflammation [30] and increased sensitivity to
experimentally induced seizures [31].
In our study, we adopted a delay fear conditioning (FC)
training paradigm in which an initially neutral conditioned
stimulus (CS), usually a tone, is simultaneously presented
or co-terminates with an unconditioned stimulus (US),
typically a foot-shock [32,33]. Following the CS-US pairing
(s), mice display an anti-predatory freezing response both
in the presence of a salient CS (tone conditioned fear
memory) or when being placed in the original training
chamber in which they experienced the US (contextual
fear conditioning memory). It has been shown that the
contextual fear memory depends on an intact hippocam-
pus [34,35], while the cued fear memory depends on an
intact amygdala [36,37].
The aim of the present study was to evaluate the contex-
tual and cued fear memory of CRND8 mice at the age of
three, six, and 12 months, which corresponded to the
onset of low, moderate, and severe Ab plaque deposition
in the brain of these mice [38], and to associate the Ab
plaque burden with the context and tone memory indices.
The results demonstrated that the Ab plaque burden sig-
nificantly increased within the studied age range, and it
was significantly associated with an overall impairment in
contextual and tone fear memory in CRND8 mice. The
oldest, 12 month-old, CRND8 mice showed impairment in
both types of memory. While the context memory of the
younger, three and six month-old, CRND8 mice was com-
parable to control littermates, the tone fear memory of the
CRND8 mice was significantly impaired at each age of
testing. The apparent increase in the sensitivity of the
detection of age-dependent onset of memory impairment
using tone fear conditioning makes this test an attractive
potential diagnostic tool during evaluation of the efficacy




The transgenic CRND8 mice over-express mutant forms
of human APP genes (Swedish; KM670/671NL + Indiana;
V717F) [26,38] implicated in AD [39,40]. This model
shows rapid onset of extra-cellular Ab deposits at 2.5 to 3
months of age, with coinciding impairment in spatial
reference memory [26]. Dense-core Ab plaques and neuri-
tic pathology appear at five months [38].
Three cohorts of transgenic (Tg) CRND8 and non-
transgenic (nTg) littermates (hybrid genetic background,
C57BL/6//C3H) at ages three (N = 27, 13/14 Tg/nTg), six
(N = 28, 11/17 Tg/nTg), and 12 (N = 24, 11/13 Tg/nTg)
months were used. The physical condition and sensorimo-
tor propensities of the CRND8 mice did not differ from
their control nTg littermates within the studied age range
as evaluated in the SHIRPA (SmithKline Beecham Phar-
maceuticals; Harwell, MRC Mouse Genome Centre and
Mammalian Genetics Unit; Imperial College School of
Medicine at St Mary’s; Royal London Hospital, St Bartho-
lomew’s and the Royal London School of Medicine; Phe-
notype Assessment) phenotyping screen (data not shown).
The cohorts within each genotype were female biased
(median for males = 3.5, for females = 9). The mice were
genotyped at weaning by analysis of tail DNA with a
human APP hybridization probe, as described previously
[38]. They were housed in same-sex groups of two to four
under standard laboratory conditions (12:12 hours light/
dark cycle, lights on at 0600 hours) with a room tempera-
ture of 21°C, and water and food available ad libitum. All
tests were performed during the light phase between 09:00
and 14:00 hours. All procedures were approved by the
Institutional Animal Care and Use Committee of Mayo
Clinic Jacksonville and are in accordance with Association
for Assessment and Accreditation of Laboratory Animal
Care International (AAALAC) and the National Institutes
of Health Guide for the Care and Use of Laboratory Ani-
mals guidelines.
Primary neurological and sensorimotor examination
The SHIRPA protocol [41,42] involves a series of tests
assessing the physical condition of the mice. The following
phenotypes are measured: (1) body position in a cage,
respiration, tremor, transfer arousal, palpebral closure,
piloerection, (2) reflexes - touch escape, pinna reflex,
trunk curl, limb grasping, visual placing, negative geotaxis
and righting reflex, and (3) grip strength. The screen takes
altogether about five to seven minutes per mouse.
Fear conditioning test
The conditioning procedure was carried out in four identi-
cal chambers (25.3L × 29.5W × 29.5H cm; Coulbourn
Instruments.). The total floor area of each chamber was
746 cm2. The chambers were constructed from aluminum
(sidewalls and ceiling) and Plexiglas (rear and front walls).
They were placed individually in sound-attenuated cabi-
nets with black inside walls (interior dimensions: 43.3L ×
55.3W × 58.5H cm; Coulbourn Instruments.), which were
located in a dedicated room. A ventilation fan in each
cabinet provided 50 dB of background noise, and a 24V
DC white light, mounted on a wall of each chamber, pro-
vided illumination (65 lux at the floor level). A speaker
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mounted in the wall opposite to the light delivered an
acoustic CS. The floor of each chamber, which consisted
of 26 stainless steel rods (3 mm in diameter) spaced 11
mm center to center, was wired to a precision-regulated
shocker (H13-15, Coulbourn Instruments). A camera
mounted above the chamber recorded mouse activity.
Conditioning was assessed by the analysis of the fear
response expressed as freezing behavior with the aid of the
FreezeFrame program (v. 3.06, Actimetrics). Freezing was
defined as the cessation of all movements other than
respiratory activity [43].
Conditioning procedure and memory tests
Mice were exposed to the context of a training chamber
and a tone, both initially novel and neutral stimuli, in one
training session. They were transported in squads of four
in individual containers filled with home cage bedding and
placed singly in the conditioning chamber. During train-
ing, the mice received two pairings between a tone (80 dB,
pulse (six clicks per second (c.p.s)), 30 seconds duration)
and a 0.45 mA foot shock (two seconds duration, co-ter-
minated with a tone). The first CS-US pairing was deliv-
ered at the end of 120 seconds of the initial exploration of
the chamber, and the second following a 60-second inter-
val. After the second CS-US pairing the mice were given a
60-second post-training period. The total duration of the
training session was 300 seconds. After a day of recovery,
the mice were returned to their respective conditioning
chambers and tested for fear-induced freezing to the con-
text in which they received foot shocks. The test, carried
out in an extinction mode with no shock administered,
lasted 300 seconds. The following day, the mice were
tested for the association between the tone and the foot-
shock in a modified chamber. The floor and the walls of
the chamber were replaced with plastic inserts (opaque
white for the floor, and semi-transparent white at the
front and opaque green at the back for the walls), which
also eliminated corners in the chamber. The total floor
area of the modified chamber was about 671 cm2. A Petri
dish containing a drop of a Pure Lemon Extract (McCor-
mick) was placed underneath the floor of each chamber to
provide a distinct novel odor in the chamber. The above
modifications did not change the light intensity in the
chamber. The tone test lasted 360 seconds. During the
first 180 seconds the mice were allowed to explore the
new environment and during the second 180 seconds a
tone, with the same characteristics as the tone used during
training, was delivered. Mice activity was recorded during
all tests.
Quantification of Ab deposition
At the end of the experiment, the mice were sacrificed
and their brains were removed. One hemi-brain was
submerged in 10% neutrally buffered formalin for
immunohistochemical analysis of Ab plaque burden.
The remaining hemisphere of the brain was snap frozen
and stored at -80°C for further analysis. Paraffin, coronal
5 μm sections were affixed to Fisher brand Superfrost/
Plus slides to ensure adhesion. Brain sections (10 to
12 sections/set) cut at 30 μm intervals within the range
of -1.22 mm to -3.08 mm from the bregma [44], includ-
ing the hippocampus and amygdala, were used for ana-
lyses. All slides were deparaffinized and immunostained
with the pan Ab 1 to 16 (33.1.1) antibody (dilution
1:5000) to visualize both diffuse and core Ab deposits. A
separate set of slides was stained by anti- Ab40 (MM32-
13.1.1) antibody (dilution 1:2000) in order to selectively
quantify core Ab deposits. Stained sections were
scanned with a high resolution, whole slide imaging sys-
tem (0.46 μm/pixel with 20X objective lens, Scan-
Scope™ XT, Aperio Technologies, Inc. Vista, CA, USA).
The images were viewed in an ImageScope™ viewer (v.
10) and the Ab-positive staining was detected using an
automated image analysis system by applying a color
deconvolution method [45] within the Hue, Saturation,
Intensity (HSI) model (Color Deconvolution algorithm,
Aperio Technologies, Inc., settings: hue value and width
= 0.1 and 0.3, respectively, and saturation threshold =
0.04). The area of the brain including the cortex, hippo-
campus, and amydgala were outlined according to the
mouse atlas [44], and the Ab burden was expressed as
the percent of outlined area stained positively for Ab.
Background staining was determined in the area of basal
ganglia, which was devoid of Ab-positive staining, and
was set to a pixel value of 40.
Data and statistical analyses
Since the experimental design included two between sub-
jects factors: genotype and age, we followed two a priori
identified approaches to data analysis. In the first, we com-
pared the conditioned fear memory between the genotypes
within the tested age range, followed by post-hoc analysis
at each age. These analyses provided answers to age-
related differences in memory scores between transgenic
and control mice. The second analytical approach focused
on the age-related changes in context and tone fear mem-
ory within each genotype. While the cross-sectional design
of the study did not eliminate between subjects variability
in the evaluation of the age-related changes within each
genotype, thus decreasing slightly the sensitivity of the
study, it allowed us to evaluate the Ab pathology at each
testing age and relate it to the obtained memory scores.
Due to significantly female-biased groups, the analysis of
possible sex effects was not performed. The overall analy-
sis of the experiment was done by a factorial analysis of
variance (ANOVA) with genotype and age as between
subject factors. Where appropriate, simple effects were
evaluated using one-way ANOVA. In analyses requiring
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multiple comparisons between means, the Bonferroni
adjustment of a level minimizing Type I (family-wise)
error rate was used [46]. A priori comparisons were per-
formed using the Bonferroni t test (MODLSD), and post-
hoc multiple pair-wise comparisons were done using the
Student-Newman-Keuls (SNK) test [46]. All statistical ana-
lyses were done using the Statistical Package for Social
Sciences (SPSS Inc. Chicago) version 19 for Macintosh.
Comparisons between two independent groups were done
using a Student t-test. Spearman’s rank correlation was
used to assess the associations between Ab burden and
freezing behavior, and partial correlation was used to eval-
uate associations while controlling for the effect of geno-
type. Due to the nonparametric nature of the data
obtained in the SHIRPA screen, these data were analyzed
using the c2 test [47]. The critical a level was set to 0.05
in all analyses. All values in the text and figures represent
means ± the standard error of the mean (SEM).
Results
Training: exploration and response to foot-shock
There was no difference between the CRND8 and control
nTg mice in the exploratory activity preceding the first
CS-US presentation (data not shown). All mice spent, on
average, less than 1% of the time on spontaneous pauses
during the120 second exploration. Overall, older mice
paused longer (F(2,73) = 4.1, P < 0.05), mainly due to
longer breaks in motor activity of 12-month-old CRND8
mice (F(2,73) = 5.8, P < 0.01, genotype by age interaction).
Twelve-month-old CRND8 mice spent 2.6% ± 0.9 of the
time immobile, which was significantly longer than their
younger counterparts (P < 0.01 and P < 0.05 for the com-
parisons with three- and six-month-old mice, respectively,
Bonferroni t-test), but this amounted only to about three
seconds of immobility during exploration. There was no
difference in activity between the age cohorts of nTg mice.
The immediate freezing response to foot-shock was sig-
nificantly lower in CRND8 mice than in nTg littermates (F
(1,73) = 29.1, P < 0.001, genotype effect, Figure 1A). Also,
the oldest mice of both genotypes tended to show less
immediate freezing than younger mice (F(2,73) = 3.0, P =
0.054, age effect, Figure 1A). The examination of the effect
of age on immediate freezing within each genotype
revealed no significant trends in the decrease of immediate
freezing in nTg or CRND8 mice (F(1,41) = 2.1, NS and F
(1,32) = 2.1, NS, respectively, ANOVA simple effects),
confirming a weak effect of age on immediate freezing.
Context fear memory
The CRND8 mice showed a significantly lower freezing
response during the context test than nTg littermates (F
(1,72) = 7.3, P < 0.01, genotype effect, Figure 1B). Overall
older mice showed weaker context memory (F(2,31) = 3.8,
P < 0.05, age effect). Post-hoc comparisons revealed that
12-month-old CRND8 mice froze significantly less than
their nTg littermates (t(22) = 3.4, P < 0.01); however, the
contextual memory of three- and six-month-old CRND8
and nTg mice was comparable. The freezing rate of the
mice during the context test was not significantly asso-
ciated with the duration of pauses during initial explora-
tion of the training chamber (r2(74) = 0.02, NS). The
analysis of age-related changes in contextual fear memory
within each genotype revealed a significant decrease in
freezing to training context in CRND8 mice (F(1,32) = 3.7,
P < 0.05, ANOVA simple effects). Post-hoc comparisons
demonstrated that 12-month-old CRND8 mice showed a
significantly lower context memory than three-month-old
mice (P < 0.05, Bonferroni t-test), but not than six-month-
old counterparts. The changes in context memory of nTg
control mice due to age were not significant (F(1,41) = 0.4,
NS, ANOVA, simple effects).
Tone fear memory
The average percent of freezing time displayed by mice
during the tone fear conditioning test is presented in
Figure 1C. Overall, CRND8 mice froze less during the
whole test than nTg mice (F(1,73) = 36.2, P < 0.001,
genotype effect). Also, all mice froze longer during the
presentation of the tone (F(1,73) = 208.2, P < 0.001,
tone effect); however the level of freezing to tone
depended on genotype (F(1,73) = 33.4, P < 0.001, geno-
type × tone interaction) and age (F(2,73) = 3.3, P < 0.05,
age × tone interaction).
The post-hoc analysis revealed that CRND8 mice froze
significantly less during the exploration of the altered
training chamber than nTg mice (F(1,73) = 12.6, P <
0.001, genotype effect, Figure 1C left panel). The six- and
12-month-old CRND8 mice froze less than their three-
month-old counterparts (P = 0.1 and P = 0.07, respec-
tively, Bonferroni t-test). The freezing rate of three-
month-old CRND8 mice was comparable to the freezing
rate of nTg mice, which showed comparable exploration
of altered context at all ages.
Overall, tone fear memory of CRND8 mice was
impaired (F(1,73) = 43.9, P < 0.001, Figure 1C right
panel, genotype effect), and was weaker in older mice (F
(2,73) = 3.3, P < 0.05, age effect). Post-hoc analysis
revealed that CRND8 mice showed a weaker memory
than their nTg controls at each age of testing (t(25) =
3.2, P < 0.01, t(26) = 3.4, P < 0.01, and t(16) = 5.4, P <
0.001, for three-, six-, and 12 month-old age cohorts,
respectively, Figure 1C, right panel). Within-genotypes
comparisons revealed that the tone memory of CRND8
mice decreased with age (F(2, 32) = 5.7, P < 0.01,
ANOVA, simple effects), mainly due to lower freezing
in 12-month-old mice (P < 0.01 and P < 0.05 for the
comparison with three- and six-month-old counterparts,
Bonferroni t-test). Tone fear memory of nTg mice was
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not affected by age (F(1,41) = 0.3, NS, ANOVA, simple
effects).
Of interest is that the significant dissociation between
age-dependent onset of the impairment in the context
and tone memory was caused by stronger tone memory
of nTg mice as compared to the strength of their con-
text memory at each age (t(13) = -2.8, P < 0.02; t(16) =
-2.4, P < 0.05; t(12) = -2.7, P < 0.02, for three, six and
A B
C








Figure 1 Mean (± SEM) percent of freezing by CRND8 mice and their non-transgenic (nTg) littermates at three, six, and 12 months of
age. (A) CRND8 mice showed significantly lower rates of freezing as compared to nTg mice immediately following the presentation of a foot
shock during training (P < 0.001 - genotype effect). (B) Overall, the context memory of CRND8 mice was impaired as compared to control nTg
mice (P < 0.01 - genotype effect). No differences in context memory were found between nTg and Tg mice at three and six months, but at 12-
months the CRND8 mice were significantly impaired (post-hoc Bonferroni t-test). (C) CRND8 mice froze significantly less than nTg mice during
the pre-tone (left panel) and the tone (right panel) phases of the test. The CRND8 mice showed significant impairment in tone fear memory at
each age of testing (right panel). Three, six, 12 on the abscissae refer to the age of testing. * P < 0.02, ** P < 0.01, *** P < 0.001.
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12 month tests, respectively). The tone and context
memory of CRND8 mice were comparable (Figure 1B
and 1C right panel).
Ab plaque burden increases with age in CRND8 mice
We previously demonstrated that amyloid plaque bur-
den was significantly correlated with sodium dodecyl
sulfate (SDS-) soluble and formic acid (FA-) extractable
Ab fractions in the CRND8 model, and that both bio-
chemical and histo-pathological analyses of Ab led to
the same interpretations of cognitive impairment in
multiple memory systems [24].
The representative pictures of the Ab plaque burden
in the brain of three-, six-, and 12-month-old CRND8
mice are shown in Figure 2. The Ab plague burden
increased with age (rS = 0.94, P < 0.001), differentiating
the age cohorts of CRND8 mice (F(2,26) = 100.6, P <
0.001, Figure 3). Post-hoc comparisons revealed differ-
ences in Ab burden between all tested age groups (3 < 6
< 12, Ps < 0.01, Bonferroni t-test, Figure 3A). Ab burden
at younger ages was most prominent in the cortical, hip-
pocampal, and amygdala regions (Figure 2AB); at 12
months the Ab deposits were observed in the whole
brain, including thalamic, hypothalamic and caudate/
amygdala regions (Figure 2C). We found a strong posi-
tive correlation between the Ab plaque burden evaluated
by staining with pan Ab 1-16 antibody and the total
number of Ab dense core deposits stained by anti-
Ab40 antibody (rS = 0.9, P < 0.001). Consequently, the
dense-core Ab burden is not reported.
Increase in Ab plaque burden impairs context and tone
fear memory
The increased-with-age levels of Ab plaque burden were
correlated with the impairment in context and tone fear
memory in CRBD8 mice (rS = -0.43, P < 0.05 for context
(Figure 3B), and rS = -0.40, P < 0.05 for tone (Figure 3C)
memory). No association was found between Ab plaque
burden and immediate freezing following foot-shock or
freezing during the pre-tone phase of the tone test.
Next, we investigated whether the variability in the Ab
plaque burden at each age of testing also reflects inverse
association with context and tone fear memory. We
found that variability in Ab plaque burden (expressed by
the coefficient of variation (CV)) increased with age,
from 17% at three months to 34%, and 27% at six and 12
months, respectively. Moreover, the variability in mem-
ory scores of CRND8 mice differed from the variability in
memory of nTg littermates. While the variance in mem-
ory scores of nTg mice was low and comparable across
age groups (73%, 76%, 60%, and 38%, 49%, 50% for three,
six, and 12 month context and tone memory, respec-
tively), the variability in memory scores of CRND8 mice
was higher, reaching high variance (CV > 100%) at the
Figure 2 Representative images of Ab deposits, stained with
pan Ab 1-16 (33.1.1) antibody, in the brain sections of (A)
three-, (B) six-, and (C) 12-month-old CRND8 mice. The total
amyloid burden in the combined areas of cortex, hippocampus and
amygdala was 11.0%, 52.9%, and 83.1%, respectively for the sections
presented in A, B, C panels.
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age of 12 months (70%, 93%, 144%, and 53%, 75%, 113%
for three, six, and 12 month context and tone memory,
respectively). While our analysis revealed no significant
association between the Ab plaque burden and the con-
text fear memory in CRND8 mice at any age of testing,
surprisingly, we found positive associations between Ab
plaque burden and tone fear memory at three (rS = 0.67,
P < 0.05) and six months of age (rS = 0.80, P < 0.01), but
not at 12 months of age (rS = 0.30, NS). Despite a much
reduced sample size, these post-hoc analyses revealed that
at the ages of three and six months, which are character-
ized by rapid Ab plaque formation, those CRND8 mice
which showed more Ab plaques, also showed higher tone
fear memory. At present, these preliminary results have
to be interpreted with caution. These findings should be
replicated in future studies and the relationship between
the soluble Ab and Ab sequestered in plaques, and also
other processes, such as reactive gliosis and inflammatory
responses should be systematically evaluated in order to
elucidate further the relationship between amyloid-b and
cognition at the early stage of plaque formation.
Discussion
The present results extend previous studies showing
that other APP mouse models exhibit impairment in
fear conditioned memory, by demonstrating that this
impairment is progressive and correlates well with over-
all Ab burden. Also, the demonstrated greater sensitivity
of the foreground tone conditioning test in the identifi-
cation of age dependent onset of the memory impair-
ment in CRND8, suggests that this testing paradigm
might be particularly suitable in studies evaluating
potential therapeutic agents related to memory improve-
ment in APP mouse models.
APP transgenic mouse models have been reported to
show memory deficits similar to those observed in AD
[21,48-53]. However, comprehensive cognitive profiles,
including multiple memory systems, have often been
based on comparative analyses from several independent
studies using APP mouse models (see [21]). In our
study, we simultaneously evaluated two memory sys-
tems; memory of the association between the context of
the training environment and a foot-shock, which
depends on the hippocampus, and memory of the asso-
ciation between a tone and a foot-shock, which is
dependent on an intact amygdala. The strength of both
types of memory in this paradigm is inferred from the
same behavior of freezing response to relevant condi-
tioned stimuli. The implementation of the delay fear
conditioning paradigm, in which an explicit cue such as
a tone is co-terminated with a foot-shock, usually results
in stronger foreground conditioning to tone and weaker
































rs = -0.43, p < 0.05
rs = -0.40, p < 0.05
Figure 3 Amyloid-b plaque burden and conditioned fear
memory in CRND8 mice. (A) The levels of amyloid-b burden
(mean (%) ± SEM) significantly increased in CRND8 mice between
the ages of three and 12 months. The progressing with age Ab
plaque burden was significantly associated with deterioration in (B)
contextual (P < 0.05) and in (C) tone (P < 0.05) fear memory in
CRND8 mice. ** P < 0.01, *** P < 0.001.
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study confirmed this prediction and demonstrated that
nTg control mice had a stronger conditioned tone fear
memory than a context fear memory. In contrast, the
foreground fear conditioning to tone did not differenti-
ate the response of CRND8 mice from their response to
the background context cues. The apparent dissociation
in the onset of the cognitive impairment of CRND8
mice in the delay conditioning paradigm has important
practical consequences. First, it stresses the importance
of the comparative analysis between genotypes across
multiple tasks, which differ in the strength of memory
development, in order to identify the ceiling perfor-
mance or maximum dynamic range of the control nTg
mice maintained on a specific genetic background. Sec-
ond, the comparison between the tasks demonstrated
that not only the impairment of CRND8 mice declined
with age, but they also were not able to reach a level of
performance comparable to nTg controls at the earlier
ages of testing when the Ab plaque burden was rela-
tively low. Moreover, the CRND8 mice showed impair-
ment in generalizing the conditioning effects to
additional cues present in the testing room, such as
characteristics of sound attenuating chambers or other
subtle cues, which despite our effort, could not be com-
pletely eliminated during the tone test. Consequently,
their freezing rates during the pre-tone phase of the test
were significantly lower than the freezing of nTg litter-
mates, especially at older ages. Our results also indicated
that the 12-month-old nTg control mice showed slightly
lower, albeit not significant, freezing rates. Although
aged, 19- to 20-month-old, C57BL/6 mice show impair-
ment in the fear conditioning memories [55], additional
studies should establish whether the decrease in the fear
conditioned freezing response occurs reliably at much
earlier ages in the hybrid C57BL/6//C3H background of
the CRND8 model. Future studies should also extend
our findings and focus on testing the CRND8 mice at
ages preceding overt amyloid-b deposition, in an
attempt to elucidate whether the impairment in condi-
tioned fear memory in this model contains an age-inde-
pendent component [56], caused by the constitutive
expression of the APP transgene. It has been demon-
strated that fear memory in another APP Tg2576 mouse
model was impaired before the first detection of soluble
oligomeric Ab species [57,58], which seems to support
this hypothesis. In summary, our results show that at 12
months of age the CRND8 mice are significantly
impaired in both context and cue fear memory, regard-
less of the salience of the available conditional stimuli,
and that the sensitivity of the delay fear conditioning
paradigm to identify the onset of impairment depended
on the dynamic range of responses shown by control lit-
termates to more salient foreground tone conditioning.
The increased salience of the tone conditioned stimulus,
which immediately preceded the foot-shock, resulted in
greater sensitivity of the detection of memory deficiency
in CRND8 mice due to the stronger shift of the nTg
mice to the salience of foreground (tone) stimulus. By
inference, our results indicate that the compromised
hippocampal-amygdala function in CRND8 mice likely
impaired the processing and the use of the more salient
conditional tone stimulus [59,60]. It is likely, then, that
the impairment in the detection of the salience of the
foreground (tone) stimulus reflects subtle differences in
the learning ability of CRND8 mice at early stages of
amyloid pathology.
The comparable context fear memory of the genotypes
at three and six months contrasts with the results of our
previous studies which demonstrated significant impair-
ment of CRND8 mice in the hippocampus-dependent
spatial reference memory evaluated in the water maze
test at these ages [26,38]. This discrepancy can be
reconciled since the spatial reference memory evaluated
in the water or Barnes mazes is not associated with con-
textual fear memory [61,62] and each of these distinct
types of memories might have different underlying
mechanisms [63], following different biological functions
and adaptive significance. It is also likely that the change
in the salience of the conditioning context [64,65] or
switching the context conditioning from background to
foreground, by eliminating the delay component of tone
presentation, might increase the sensitivity of the con-
text testing paradigm in identifying the impairment of
the CRND8 mice in this type of memory at earlier ages.
The advantage of the fear conditioning testing paradigm
lies in its rapid development of robust and long-lasting
memory, which is based on an evolutionary anti-preda-
tory fear response preserved across many species,
including humans. This paradigm, with its long lasting
memory of the CS-US association provides easier imple-
mentation of tests focusing on memory acquisition, for-
getting and extinction, and it is less physically
demanding than the water maze test.
Our study also confirmed the early age of onset [38],
followed by rapidly progressing Ab deposition in
CRND8 mice. The deposition of Ab plaques increased
about 12-fold between three- and six- month and four-
fold between six- and 12-month-old mice. This increase
in Ab plaque burden was significantly correlated with
the decline in contextual and tone fear memory. The
importance of these results lies in the validation of the
CRND8 model as a research tool which is sensitive to
reveal the relationship between Ab accumulation and
cognitive function, with the potential to evaluate the
efficacy of pre-clinical therapeutic approaches aiming at
improvement of the cognitive function.
There is considerable controversy related to the func-
tional link between the insoluble Ab residing in plaques
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and cognitive dysfunction in AD [66-69] or in normal
aged individuals [70]. However, the available post mor-
tem evidence indicates significant associations between
amyloid pathology and cognition in AD patients
[6,71-73], with total amyloid load or burden being the
most reliable and powerful manifestation of clinically
diagnosed dementia [74]. While Ab plaque burden does
not likely represent the immediate causal factor underly-
ing dementia, our results suggest that it might be a
robust surrogate marker indicating the severity of the
impairment, at least in the fear conditioning paradigm
applied in pre-clinical research using mouse models.
Conclusions
The advantage of applying the fear conditioning para-
digm to evaluate cognitive dysfunction in human studies
is that the test focuses on nondeclarative, unconscious
memory, which depends on frontal and temporal
regions, including cortical sensory processing areas, the
thalamus, and the amygdala [75-77]. Several studies
demonstrated that in humans fear conditioned memory
also depends on the same neural structures that are
affected at the early stage of AD [78-81]. Also, unlike
declarative or conscious memory, nondeclarative, impli-
cit memory depends less on subjective recall and recog-
nition of information [82,83], providing a better
comparative platform between pre-clinical studies invol-
ving animal models, and clinical studies of human
dementia with neurodegeneration. Although few studies
have demonstrated that fear conditioned memory is
impaired in AD [84] and in frontotemporal lobar degen-
eration [85] (of note, an unconditional stimulus used in
these studies was a one second burst of 100 db white
noise presented through headphones), the association
between the impairment in implicit memory and amy-
loid plaque load in AD patients assessed in vivo [86] has
yet to be addressed.
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